Connect with us

Hi, what are you looking for?

Jewish Business News


Israeli Hi-Tech Businesses Continue to Thrive During War

Atox Bio

The conflict between Israel and Hamas is not causing Israeli businesses to hide out in the trenches.

Please help us out :
Will you offer us a hand? Every gift, regardless of size, fuels our future.
Your critical contribution enables us to maintain our independence from shareholders or wealthy owners, allowing us to keep up reporting without bias. It means we can continue to make Jewish Business News available to everyone.
You can support us for as little as $1 via PayPal at
Thank you.

Rocket fire and negative media coverage do not seem to be effective weapons against business and technology. Atox Bio announced funding to the tune of $23 million for its flesh-eating bacteria treatment.

The problem of spontaneous destruction of the body’s tissues after the introduction of bacteria has horrified and perplexed doctors, patients and readers of tabloid headlines alike. Atox developed a drug called AB 103 will be given a late-phase study after passing phase 2 with flying colors, and venture capital funds of the companies GlaxoSmithKline, Lundbeck’s and OrbiMed are investing the money to enable final testing and hopefully, approval of Atox’s drug.

Tel Aviv-based V-Gen is going to be bought by the Newport Corporation of California for an amount in the range of $15 million and $20 million. V-Gen is a fast-grower in the laser beam space and specializes in fiber lasers.

Unlike the downsizing that happens in the aftermath of mergers, the 50 employees at V-Gen are going to be retained after the company is purchased. CEO Eran Inbar expressed enthusiasm over the deal, and said that Newport’s “worldwide sales and service network and complementary technologies will enable us to expand our business beyond what we could have achieved as a stand-alone company. Together we will provide innovative laser solutions for both existing and emerging applications.”




You May Also Like

World News

In the 15th Nov 2015 edition of Israel’s good news, the highlights include:   ·         A new Israeli treatment brings hope to relapsed leukemia...


The Movie The Professional is what made Natalie Portman a Lolita.


After two decades without a rating system in Israel, at the end of 2012 an international tender for hotel rating was published.  Invited to place bids...

VC, Investments

You may not become a millionaire, but there is a lot to learn from George Soros.